<VariationArchive RecordType="classified" VariationID="1326258" VariationName="NM_006259.3(PRKG2):c.491dup (p.Asn164fs)" VariationType="Duplication" Accession="VCV001326258" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-01-22" MostRecentSubmission="2022-01-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1316582" VariationID="1326258">
      <GeneList>
        <Gene Symbol="PRKG2" FullName="protein kinase cGMP-dependent 2" GeneID="5593" HGNC_ID="HGNC:9416" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>4q21.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="81087370" stop="81217836" display_start="81087370" display_stop="81217836" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="82009836" stop="82126214" display_start="82009836" display_stop="82126214" Strand="-" />
          </Location>
          <OMIM>601591</OMIM>
        </Gene>
        <Gene Symbol="PRKG2-AS1" FullName="PRKG2 antisense RNA 1" GeneID="101928942" HGNC_ID="HGNC:40478" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>4q21.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="81164940" stop="81193395" display_start="81164940" display_stop="81193395" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_006259.3(PRKG2):c.491dup (p.Asn164fs)</Name>
      <CanonicalSPDI>NC_000004.12:81174929:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4q21.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="81174929" stop="81174930" display_start="81174929" display_stop="81174930" variantLength="1" positionVCF="81174929" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="82096083" stop="82096084" display_start="82096083" display_stop="82096084" variantLength="1" positionVCF="82096083" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>N164fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.82096085dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.82096085dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.81174931dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.81174931dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282485.2" sequenceAccession="NM_001282485" sequenceVersion="2" change="c.491dup">
            <Expression>NM_001282485.2:c.491dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269414.1" sequenceAccession="NP_001269414" sequenceVersion="1" change="p.Asn164fs">
            <Expression>NP_001269414.1:p.Asn164fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363401.2" sequenceAccession="NM_001363401" sequenceVersion="2" change="c.491dup">
            <Expression>NM_001363401.2:c.491dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350330.1" sequenceAccession="NP_001350330" sequenceVersion="1" change="p.Asn164fs">
            <Expression>NP_001350330.1:p.Asn164fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006259.3" sequenceAccession="NM_006259" sequenceVersion="3" change="c.491dup" MANESelect="true">
            <Expression>NM_006259.3:c.491dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006250.1" sequenceAccession="NP_006250" sequenceVersion="1" change="p.Asn164fs">
            <Expression>NP_006250.1:p.Asn164fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601591.0002" DB="OMIM" />
        <XRef Type="rs" ID="2110087773" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006259.3(PRKG2):c.491dup (p.Asn164fs) AND Acromesomelic dysplasia 4" Accession="RCV001786319" Version="3">
        <ClassifiedConditionList TraitSetID="71039">
          <ClassifiedCondition DB="MedGen" ID="C5562028">Acromesomelic dysplasia 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-01-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-01-22" MostRecentSubmission="2022-01-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">33106379</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="71039" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="60941" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Acromesomelic dysplasia 4</ElementValue>
                <XRef ID="MONDO:0030553" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AMD4</ElementValue>
                <XRef Type="MIM" ID="619636" DB="OMIM" />
              </Symbol>
              <XRef ID="C5562028" DB="MedGen" />
              <XRef ID="MONDO:0030553" DB="MONDO" />
              <XRef Type="MIM" ID="619636" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3971908" SubmissionDate="2022-01-18" DateLastUpdated="2022-01-22" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="601591.0002_ACROMESOMELIC DYSPLASIA 4" title="PRKG2, 1-BP DUP, NT491_ACROMESOMELIC DYSPLASIA 4" />
        <ClinVarAccession Accession="SCV002028287" DateUpdated="2022-01-22" DateCreated="2021-11-29" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 11-year-old Indian girl (proband 2) with disproportionate short stature due to acromesomelic dysplasia (AMD4; 619636), Diaz-Gonzalez et al. (2022) identified homozygosity for a 1-bp duplication (c.491dup, NM_006259.2) in exon 3 of the PRKG2 gene, causing a frameshift predicted to result in a premature termination codon (Asn164LysfsTer2) and a protein lacking both the regulatory and catalytic domains. Her unaffected parents were heterozygous for the mutation, which was not found in the gnomAD database. The mutant protein was detected in transfected HEK293T cells, but its expression level was reduced compared to that of wildtype protein; analysis of patient peripheral blood mononuclear cells in the presence or absence of the nonsense-mediated decay (NMD) inhibitor CHX indicated that the mutant undergoes NMD. The N164KfsTer2 mutant also altered the downstream mitogen-activated protein kinase (MAPK) signaling pathway by failing to phosphorylate RAF1 (164760) at S43, which in turn fails to reduce ERK1 (MAPK3; 601795)/2 (MAPK1; 176948) activation in response to FGF2 (134920). In addition, unlike wildtype PRKG2, the N164KfsTer2 mutant was unable to downregulate COL2A1 (120140) or upregulate COL10A1 (120110) mRNA levels.</Attribute>
              <Citation>
                <ID Source="PubMed">33106379</ID>
              </Citation>
              <XRef DB="OMIM" ID="619636" Type="MIM" />
              <XRef DB="OMIM" ID="164760" Type="MIM" />
              <XRef DB="OMIM" ID="601795" Type="MIM" />
              <XRef DB="OMIM" ID="176948" Type="MIM" />
              <XRef DB="OMIM" ID="134920" Type="MIM" />
              <XRef DB="OMIM" ID="120140" Type="MIM" />
              <XRef DB="OMIM" ID="120110" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKG2" />
          </GeneList>
          <Name>PRKG2, 1-BP DUP, NT491</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, NT491</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601591.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ACROMESOMELIC DYSPLASIA 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3971908" TraitType="Disease" MappingType="Name" MappingValue="ACROMESOMELIC DYSPLASIA 4" MappingRef="Preferred">
        <MedGen CUI="C5562028" Name="Acromesomelic dysplasia 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

